The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Share News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,846.00
Bid: 1,826.00
Ask: 1,840.00
Change: 0.00 (0.00%)
Spread: 14.00 (0.767%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,846.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Genus Posts "Very Strong" Interim Results Despite Covid-19 Impact

Thu, 25th Feb 2021 09:42

(Alliance News) - Genus PLC on Thursday reported a "very strong" performance" and made "good" strategic progress in the first half of its 2021 financial year.

The Basingstoke, Hampshire-based company sells products made using biotechnology to cattle and pig farmers. It recorded revenue for the six moths ended December 31 of GBP285.7 million, a rise of 6% from GBP270.7 million in 2019.

Pretax profit for the period was GBP38.7 million, a substantial increase of 27% from GBP30.4 million in 2019.

Genus said these increases are due to a "strong" revenue growth of 6% in actual currency and 11% in constant currency. Its porcine genetics business saw an 8% increase, while its bovine genetics business grew by 17%, particularly in Brazil, Russia, India and China.

As a result of "strong earnings growth and cash flow generation", the company has declared an interim dividend of 10.3 pence, which is a 10% increase from 9.4p the previous year.

Shares in Genus were down 4.9% at 4,984.98p in London on Thursday.

"The group continued to show its resilience during the Covid-19 pandemic. Both PIC and ABS grew adjusted operating profits in double digits, with China, Brazil, India and Russia, being notably high growth markets. The porcine genetics business' expansion in China was significant, gaining share with large producers that have been re-stocking following the spread of African Swine Fever in 2019. Europe's growth was also very strong reflecting success with key accounts, leveraging our genetics and supply chain," said Chief Executive Stephen Wilson.

"The bovine genetics business' volume growth in the half was a record, driven by the continued success of Sexcel, and strong performance by our proprietary NuEra beef business. Latin America, Europe and Asia all grew strongly, and ABS's adjusted operating margin improved through better product mix and operating leverage," Wilson added.

Looking ahead, Genus said it will remain "resilient" as the the Covid-19 pandemic continues and expects trading to be in line with its 2021 expectations.

"In the second half of the 2021 fiscal year, we expect that growth will be lower and there are increased currency headwinds. Nevertheless, Genus continues to have significant growth opportunities and the board's expectations remain unchanged for the full year," Wilson said.

By Zoe Wickens; zoewickens@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 Nov 2020 15:59

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
12 Nov 2020 15:57

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
10 Sep 2020 09:28

UK BROKER RATINGS SUMMARY: Hargreaves Lansdown, Rio Tinto Get Upgrades

UK BROKER RATINGS SUMMARY: Hargreaves Lansdown, Rio Tinto Get Upgrades

Read more
8 Sep 2020 09:40

Genus Profit Surges In Full Year As Revenue And Value Of Assets Rises

Genus Profit Surges In Full Year As Revenue And Value Of Assets Rises

Read more
8 Sep 2020 08:40

Restockng drive in China sees Genus's free cash flow more than triple

(Sharecast News) - Genus posted a big uplift in profits before tax with cash flows more than tripling thanks to strong sales in China.

Read more
1 Sep 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
29 Jun 2020 09:20

Genus Appoints Former Tate & Lyle Boss Ferguson As Chair Designate

Genus Appoints Former Tate & Lyle Boss Ferguson As Chair Designate

Read more
29 Jun 2020 07:55

LONDON MARKET PRE-OPEN: Genus Gets New Chair; Indivior Promotes CFO

LONDON MARKET PRE-OPEN: Genus Gets New Chair; Indivior Promotes CFO

Read more
18 Jun 2020 09:40

UK BROKER RATINGS SUMMARY: Berenberg Downgrades Carnival To Sell

UK BROKER RATINGS SUMMARY: Berenberg Downgrades Carnival To Sell

Read more
12 Jun 2020 10:23

Baillie Gifford UK Growth Net Asset Value Falls But Beats Benchmark

Baillie Gifford UK Growth Net Asset Value Falls But Beats Benchmark

Read more
30 Apr 2020 09:45

UK BROKER RATINGS SUMMARY: ODDO BHF Cuts IAG To Neutral From Buy

UK BROKER RATINGS SUMMARY: ODDO BHF Cuts IAG To Neutral From Buy

Read more
30 Apr 2020 08:09

LONDON BRIEFING: Shell Cuts Dividend As Earnings Drop Almost 50%

LONDON BRIEFING: Shell Cuts Dividend As Earnings Drop Almost 50%

Read more
20 Apr 2020 15:56

Director dealings: Genus' company secretary lowers stake

(Sharecast News) - Genus revealed on Monday that general counsel and company secretary Dan Hartley had offloaded 7,500 ordinary shares in the FTSE 250-listed animal semen merchant.

Read more
20 Apr 2020 14:07

UK DIRECTOR DEALINGS SUMMARY: Genus Senior Exec Sells GBP270,000 Worth

UK DIRECTOR DEALINGS SUMMARY: Genus Senior Exec Sells GBP270,000 Worth

Read more
15 Apr 2020 15:35

FTSE 250 movers: JD Wetherspoon hit by expectations for prolonged period of low demand

(Sharecast News) - Leisure-related shares paced declines on the second-tier index on Wednesday, as investors' attention pivoted back to the sector as risk appetite soured on the back of exceedingly weak economic reports and corporate updates Stateside.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.